SkinVision
AI-powered skin cancer detection app that provides a risk assessment for uploaded skin spots and is CE-certified under EU MDR Class IIa.
Last updated: June 5, 2026
Back to directoryAI symptom checker and health assistant that asks adaptive questions and returns possible causes or next-step guidance.
Organizations comparing patient-facing symptom collection and education tools where emergency escalation, privacy, and clinical boundaries can be tested.
Compare within workflow: Patient access, triage, and agents · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating Ubie as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk patient-facing symptom assessment; confirm jurisdiction, intended use, labeling, and whether the deployment changes care-routing or regulated-device obligations. |
|---|---|
| Privacy | Review Ubie's collection of health inputs, medication and appointment information, account data, analytics, transfers, retention, and any enterprise agreement before directing patients to it. |
| Evidence | Validate triage, possible-cause, and red-flag behavior against local protocols and population needs rather than relying only on global accuracy or publication-count claims. |
| Workflow | Use only with clear warnings, emergency instructions, escalation paths, and a plan for how patients move from self-check output to appropriate care. |
Ubie describes an AI symptom checker that uses a short questionnaire to generate possible causes and says its medical information is based on publications and provider input; its privacy policy lists health-related inputs, symptom history, medication details, and healthcare-visit information as data that may be processed.
Not for: Emergency diagnosis, final medical advice, treatment decisions, or reassurance without local clinical escalation and consumer privacy review.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.